Effect of circular RNA hsa_circ_0002203 on the proliferation, migration, invasion, and apoptosis of oral squamous cell carcinoma cells

doi:10.7518/hxkq.2019.05.011

Abstract

Abstract:

Objective To investigate the effect of circular RNA hsa_circ_0002203 on the malignant biological behavior of oral squamous cell carcinoma (OSCC) cell lines. Methods Forty patients with oral squamous cell carcinoma were included. Real-time fluorescent polymerase chain reaction (PCR） was used to detect the expression level of circular RNA hsa_circ_ 0002203 in OSCC and corresponding adjacent tissues, OSCC cell lines, and human oral keratinocytes (HOK). SCC15 and CAL27 cells were transfected with lentivirus. The expression level of circular RNA hsa_circ_0002203 was detected by real-time fluorescent PCR. Cell proliferation was detected by cell counting assay (CCK-8). Cell migration and invasion ability was detected by scratch assay and Transwell migration and invasion assay. Apoptosis level was detected by flow cytometry. The expression of corresponding protein was detected by Western blot. Murine tumor formation experiments were performed to observe the effect of hsa_circ_0002203 on the tumorigenesis of SCC15 cells in vivo. Results The expression of circular RNA hsa_circ_0002203 in OSCC tissues was lower than that in adjacent tissues (P<0.01), and the expression in OSCC cell lines was lower than that in HOK (P<0.001). Hsa_circ_ 0002203 expression increased after the lentiviral infection of SCC15 and CAL27. The proliferation, migration, and invasion of SCC15 and CAL27 reduced, and apoptosis level was promoted. The tumor volume, weight decreased, and growth rate of nude mice decreased. Conclusion The low expression of circular RNA hsa_circ_0002203 in oral squamous cell carcinoma can enhance the proliferation, migration, and invasion of cancer cells and inhibit tumor cell apoptosis.

Key words: oral squamous cell carcinoma, circular RNA hsa_circ_0002203, proliferation, migration, invasion

CLC Number:

R739.8

Su Wen,Wang Yufan,Wang Feng,Yang Huijun,Yang Hongyu. Effect of circular RNA hsa_circ_0002203 on the proliferation, migration, invasion, and apoptosis of oral squamous cell carcinoma cells[J]. West China Journal of Stomatology, 2019, 37(5): 509-515.

Figures/Tables 8

Fig. 1

Fig. 2

Fig. 3

Fig. 4

Fig. 5

Fig. 6

Tab 1

Fig. 7

References 24

[1]	Vigneswaran N, Williams MD . Epidemiologic trends in head and neck cancer and aids in diagnosis[J]. Oral Maxillofac Surg Clin North Am, 2014,26(2):123-141.
[2]	Scully C, Bagan J . Oral squamous cell carcinoma overview[J]. Oral Oncol, 2009,45(4/5):301-308.
[3]	Jemal A, Bray F, Center MM , et al. Global cancer statistics[J]. CA Cancer J Clin, 2011,61(2):69-90.
[4]	Torre LA, Bray F, Siegel RL , et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015,65(2):87-108.
[5]	Salzman J, Gawad C, Wang PL , et al. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types[J]. PLoS One, 2012,7(2):e30733.
[6]	Lasda E, Parker R . Circular RNAs: diversity of form and function[J]. RNA, 2014,20(12):1829-1842.
[7]	Jeck WR, Sorrentino JA, Wang K , et al. Circular RNAs are abundant, conserved, and associated with ALU repeats[J]. RNA, 2013,19(2):141-157.
[8]	Dou YC, Cha DJ, Franklin JL , et al. Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes[J]. Sci Rep, 2016,6:37982.
[9]	Ahmed I, Karedath T, Andrews SS , et al. Altered expression pattern of circular RNAs in primary and metastatic sites of epithelial ovarian carcinoma[J]. Oncotarget, 2016,7(24):36366-36381.
[10]	Chen J, Li Y, Zheng Q , et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer[J]. Cancer Lett, 2017,388:208-219.
[11]	Xia WJ, Qiu MT, Chen R , et al. Circular RNA has_circ_0067934 is upregulated in esophageal squamous cell carcinoma and promoted proliferation[J]. Sci Rep, 2016,6:35576.
[12]	Yang P, Qiu ZJ, Jiang Y , et al. Silencing of cZNF292 circular RNA suppresses human glioma tube formation via the Wnt/β-catenin signaling pathway[J]. Oncotarget, 2016,7(39):63449-63455.
[13]	Kristensen LS, Hansen TB, Venø MT , et al. Circular RNAs in cancer: opportunities and challenges in the field[J]. Oncogene, 2018,37(5):555-565.
[14]	Wang LP, Wei YX, Yan YY , et al. CircDOCK1 suppresses cell apoptosis via inhibition of miR-196a-5p by targeting BIRC3 in OSCC[J]. Oncol Rep, 2018,39(3):951-966.
[15]	Chen L, Zhang S, Wu J , et al. circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family[J]. Oncogene, 2017,36(32):4551-4561.
[16]	Thomson PJ . Oral carcinogenesis[M] //Thomson PJ. Oral precancer-diagnosis and management of potentially malignant disorders. Chichester: Wiley Blackwell, 2012: 31-47.
[17]	Hansen TB, Jensen TI, Clausen BH , et al. Natural RNA circles function as efficient microRNA sponges[J]. Nature, 2013,495(7441):384-388.
[18]	Kefas B, Godlewski J, Comeau L , et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma[J]. Cancer Res, 2008,68(10):3566-3572.
[19]	Du WW, Fang L, Yang WN , et al. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity[J]. Cell Death Differ, 2017,24(2):357-370.
[20]	Wang YF, Li BW, Sun S , et al. Circular RNA expression in oral squamous cell carcinoma[J]. Front Oncol, 2018,8:398.
[21]	Campbell KJ, Tait SW . Targeting BCL-2 regulated apoptosis in cancer[J]. Open Biol, 2018,8(5):180002.
[22]	Liu ZQ, Ding Y, Ye N , et al. Direct activation of bax protein for cancer therapy[J]. Med Res Rev, 2016,36(2):313-341.
[23]	Jacob A, Jing J, Lee J , et al. Rab40b regulates trafficking of MMP2 and MMP9 during invadopodia formation and invasion of breast cancer cells[J]. J Cell Sci, 2013,126(20):4647-4658.
[24]	Ramos-García P, González-Moles MÁ, González-Ruiz L , et al. Prognostic and clinicopathological significance of cyclin D1 expression in oral squamous cell carcinoma: a systematic review and meta-analysis[J]. Oral Oncol, 2018,83:96-106.

蛋白	SCC15				CAL27
蛋白	实验组	对照组	t值	P值	实验组	对照组	t值	P值
BAX	1.18±0.03	1.00±0.01	6.55	<0.01	1.40±0.04	0.99±0.01	9.75	<0.01
Bcl-2	0.51±0.03	1.00±0.01	16.43	<0.01	0.68±0.03	1.00±0.06	4.78	<0.01
CyclinD1	0.44±0.02	1.03±0.07	8.71	<0.01	0.76±0.02	1.05±0.05	5.44	<0.01
MMP-9	0.46±0.02	1.07±0.05	11.55	<0.01	0.55±0.03	1.02±0.05	8.44	<0.01